These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9131089)

  • 1. [Therapy of primary dementia based on modern concepts].
    Nervenarzt; 1995 May; 66(5 Suppl):1-4. PubMed ID: 9131089
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicergoline: parallel evolution of clinical trial methodology and drug development in dementias.
    Crook TH
    Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():22-6. PubMed ID: 9205835
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):119-22. PubMed ID: 21434467
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 6. Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
    Saletu B; Anderer P; Semlitsch HV
    Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():12-21. PubMed ID: 9205834
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered neurotransmission and signal transduction: targets for nicergoline treatment.
    Winblad B
    Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():2-5. PubMed ID: 9205832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of nicergoline.
    Winblad B; Fioravanti M; Dolezal T; Logina I; Milanov IG; Popescu DC; Solomon A
    Clin Drug Investig; 2008; 28(9):533-52. PubMed ID: 18666801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
    Herrmann WM; Stephan K; Gaede K; Apeceche M
    Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementia and small vessel diseases of the brain].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):105-10. PubMed ID: 25389540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha-blockers and treatment of coronary artery vasospasm].
    Weber S; Chapsal J; Pipeau C; Degeorges M
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():131-6. PubMed ID: 6134505
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant therapy for dementia: informed consent.
    Walsh AC
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):463. PubMed ID: 1422177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dementia-related diseases. Propentofyllin--a neuroprotective glia cell modulator].
    Nervenarzt; 1998 Feb; 69(2 Suppl Propentofy):1-4. PubMed ID: 9532231
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical investigations with ateroid in old-age dementias.
    Ban TA; Morey LC; Santini V
    Semin Thromb Hemost; 1991; 17 Suppl 2():161-3. PubMed ID: 1719637
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current antidementive therapy].
    Perneczky R; Kurz A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia.
    Wieringa GE; Burlinson S; Rafferty JA; Gowland E; Burns A
    Int J Geriatr Psychiatry; 1997 Mar; 12(3):359-62. PubMed ID: 9152721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The vertebral artery syndrome and patient management tactics].
    Panteleeva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):46-50. PubMed ID: 23388592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats.
    Huang JL; Fu ST; Jiang YY; Cao YB; Guo ML; Wang Y; Xu Z
    Pharmacol Biochem Behav; 2007 Apr; 86(4):741-8. PubMed ID: 17448528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease in South Carolina, 1998.
    Cornman CB; Lane MJ; Davis DR; Sanderson M
    J S C Med Assoc; 2000 Jan; 96(1):18-21. PubMed ID: 10670175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.